Works matching IS 02704137 AND DT 2023 AND VI 83 AND IP 7

Results: 15

Issue Information.

Published in:: Prostate, 2023, v. 83, n. 7, p. 617, doi. 10.1002/pros.24385
Publication type:: Article

hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer.

Published in:

Prostate, 2023, v. 83, n. 7, p. 628, doi. 10.1002/pros.24496

By:

Adams, Mark N.;
Croft, Laura V.;
Urquhart, Aaron;
Saleem, Mohamed Ashick Mohamed;
Rockstroh, Anja;
Duijf, Pascal H. G.;
Thomas, Patrick B.;
Ferguson, Genevieve P.;
Najib, Idris Mohd;
Shah, Esha T.;
Bolderson, Emma;
Nagaraj, Shivashankar;
Williams, Elizabeth D.;
Nelson, Colleen C.;
O'Byrne, Kenneth J.;
Richard, Derek J.

Publication type:

Article

Cardiovascular outcomes among patients with castration‐resistant prostate cancer: A comparative safety study using US administrative claims data.

Published in:

Prostate, 2023, v. 83, n. 7, p. 729, doi. 10.1002/pros.24510

By:

Conover, Mitchell M.;
Weaver, James;
Fan, Bo;
Leitz, Gerhard;
Richarz, Ute;
Li, Qing;
Gifkins, Dina

Publication type:

Article

Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US‐based insurance claims database.

Published in:

Prostate, 2023, v. 83, n. 7, p. 722, doi. 10.1002/pros.24509

By:

Lee, Sinyeong;
Yoo, Koo Han;
Kim, Taek Sang;
Cho, Hyuk Jin;
Kim, Wansuk;
Oh, Jin Kyu;
Li, Shufeng;
Kim, Sang Youn;
Wei, Wuran;
Huang, Jianlin;
van Uem, Stefanie;
Del Giudice, Francesco;
Lindars, David P.;
Sathe, Abha R.;
Chung, Benjamin I.

Publication type:

Article

Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.

Published in:

Prostate, 2023, v. 83, n. 7, p. 713, doi. 10.1002/pros.24508

By:

Babar, Mustufa;
Loloi, Justin;
Tang, Kevin;
Singh, Sandeep;
Ines, Matthew;
Patel, Rutul D.;
Iqbal, Nazifa;
Ciatto, Michael

Publication type:

Article

Quality of life in patients who underwent robot‐assisted radical prostatectomy compared with those who underwent low‐dose‐rate brachytherapy.

Published in:

Prostate, 2023, v. 83, n. 7, p. 701, doi. 10.1002/pros.24507

By:

Nakai, Yasushi;
Tanaka, Nobumichi;
Asakawa, Isao;
Hori, Shunta;
Miyake, Makito;
Yamaki, Kaori;
Anai, Satoshi;
Torimoto, Kazumasa;
Inoue, Takeshi;
Hasegawa, Masatoshi;
Fujimoto, Kiyohide

Publication type:

Article

The association of type and number of high‐risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy.

Published in:

Prostate, 2023, v. 83, n. 7, p. 695, doi. 10.1002/pros.24505

By:

Chierigo, Francesco;
Flammia, Rocco Simone;
Sorce, Gabriele;
Hoeh, Benedikt;
Hohenhorst, Lukas;
Tian, Zhe;
Saad, Fred;
Graefen, Marcus;
Gallucci, Michele;
Briganti, Alberto;
Montorsi, Francesco;
Chun, Felix K. H.;
Shariat, Shahrokh F.;
Guano, Giovanni;
Mantica, Guglielmo;
Borghesi, Marco;
Suardi, Nazareno;
Terrone, Carlo;
Karakiewicz, Pierre I.

Publication type:

Article

Prospective role of 3βHSD1 in prostate cancer precision medicine.

Published in:

Prostate, 2023, v. 83, n. 7, p. 619, doi. 10.1002/pros.24504

By:

Zhuang, Qian;
Huang, Shengsong;
Li, Zhenfei

Publication type:

Article

Quality of life outcomes for patients with metastatic castration‐resistant prostate cancer and pretreatment prognostic score.

Published in:

Prostate, 2023, v. 83, n. 7, p. 688, doi. 10.1002/pros.24503

By:

Oyenuga, Mosunmoluwa;
Halabi, Susan;
Oyenuga, Abayomi;
McSweeney, Sean;
Morgans, Alicia K.;
Ryan, Charles J.;
Prizment, Anna

Publication type:

Article

Factors impacting on sexual function among men on active surveillance for prostate cancer.

Published in:

Prostate, 2023, v. 83, n. 7, p. 678, doi. 10.1002/pros.24502

By:

Tiruye, Tenaw;
O'Callaghan, Michael;
Ettridge, Kerry;
Jay, Alex;
Santoro, Kerry;
Moretti, Kim;
Beckmann, Kerri

Publication type:

Article

Mass spectrometry redefines optimal testosterone thresholds in prostate cancer patients undergoing androgen deprivation therapy.

Published in:

Prostate, 2023, v. 83, n. 7, p. 670, doi. 10.1002/pros.24501

By:

Beck, Jérémie;
Rouleau, Mélanie;
Lemire, Francis;
Neveu, Bertrand;
Déry, Michel;
Thériault, Benoît;
Dubois, Gabriel;
Guérette, Dominique;
Pouliot, Frédéric

Publication type:

Article

Prevalence of genotoxic bacteria in men undergoing biopsy for prostate cancer.

Published in:

Prostate, 2023, v. 83, n. 7, p. 663, doi. 10.1002/pros.24500

By:

Lee, John;
Wickes, Brian L.;
Fu, Jianmin;
Brockman, Nohelli E.;
Garg, Harshit;
Jobin, Christian;
Johson‐Pais, Teresa;
Leach, Robin;
Lai, Zhao;
Liss, Michael A.

Publication type:

Article

Feasibility and preliminary clinical tolerability of low‐field MRI‐guided prostate biopsy.

Published in:

Prostate, 2023, v. 83, n. 7, p. 656, doi. 10.1002/pros.24499

By:

Sze, Christina;
Singh, Zorawar;
Punyala, Ananth;
Satya, Poorvi;
Sadinski, Molly;
Narayan, Ramkrishnan;
Nacev, Aleksander;
Kumar, Dinesh;
Adams, John;
Nicholas, Kathryn;
Margolis, Daniel;
Chughtai, Bilal

Publication type:

Article

Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancer.

Published in:

Prostate, 2023, v. 83, n. 7, p. 649, doi. 10.1002/pros.24498

By:

Lewis, Akeem R.;
Costello, Brian A.;
Quevedo, Fernando;
Pagliaro, Lance C.;
Sanhueza, Cristobal;
Weinshilboum, Richard M.;
Kalari, Krishna R.;
Wang, Liewei;
Kohli, Manish;
Tan, Winston;
Giridhar, Karthik V.

Publication type:

Article

Clinical, pathologic, and molecular features of amphicrine prostate cancer.

Published in:

Prostate, 2023, v. 83, n. 7, p. 641, doi. 10.1002/pros.24497

By:

Graham, Laura S.;
Haffner, Michael C.;
Sayar, Erolcan;
Gawne, Agnes;
Schweizer, Michael T.;
Pritchard, Colin C.;
Coleman, Ilsa;
Nelson, Peter S.;
Yu, Evan Y.

Publication type:

Article